Article
TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer
13 Apr 2025
Abstract excerpt
Chemoresistance is the most significant challenge affecting the clinical efficacy of the treatment of patients with gastric cancer (GC). Here we reported that transmembrane protein 160 (TMEM160) suppressed ferroptosis and induced chemoresistance in GC cells. Mechanistically, TMEM160 recruited the E3 ligase TRIM37 to promote K48-linked ubiquitination and degradation of KEAP1, thereby activating NRF2 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
